Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Burris

Showing results (71-80 of 114) with videos related to

Pageof 12
Sort By:
Seminars in Oncology|March 4, 2000
Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancerH A Burris, J D Hainsworth, J B Erland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001
Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trialJ D Hainsworth, H A Burris, D A Yardley, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
New anticancer agentsG R Weiss, H A Burris 3rd, J R Eckardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapyA Y Bedikian, G R Weiss, S S Legha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalationD A Rinaldi, H A Burris, F A Dorr, et al.
Anti-Cancer Drugs|April 1, 1994
Phase I trial of sulofenur (LY186641) given orally on a daily x 21 scheduleT D Brown, T J O'Rourke, J G Kuhn, et al.
American Journal of Clinical Oncology|December 1, 1994
A phase II trial of DaunoXome, liposome-encapsulated daunorubicin, in patients with metastatic adenocarcinoma of the colonJ R Eckardt, E Campbell, H A Burris, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
A phase I and pharmacokinetics study of 2-chlorodeoxyadenosine in patients with solid tumorsG R Weiss, J G Kuhn, J Rizzo, et al.
British Journal of Cancer|May 8, 2014
Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignanciesA R Tan, A Dowlati, M N Stein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Phase I and pharmacokinetic trial of weekly CPT-11M L Rothenberg, J G Kuhn, H A Burris, et al.
Pageof 12

Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
Seminars in Oncology|March 4, 2000
Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancerH A Burris, J D Hainsworth, J B Erland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001
Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trialJ D Hainsworth, H A Burris, D A Yardley, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
New anticancer agentsG R Weiss, H A Burris 3rd, J R Eckardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapyA Y Bedikian, G R Weiss, S S Legha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalationD A Rinaldi, H A Burris, F A Dorr, et al.
Anti-Cancer Drugs|April 1, 1994
Phase I trial of sulofenur (LY186641) given orally on a daily x 21 scheduleT D Brown, T J O'Rourke, J G Kuhn, et al.
American Journal of Clinical Oncology|December 1, 1994
A phase II trial of DaunoXome, liposome-encapsulated daunorubicin, in patients with metastatic adenocarcinoma of the colonJ R Eckardt, E Campbell, H A Burris, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
A phase I and pharmacokinetics study of 2-chlorodeoxyadenosine in patients with solid tumorsG R Weiss, J G Kuhn, J Rizzo, et al.
British Journal of Cancer|May 8, 2014
Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignanciesA R Tan, A Dowlati, M N Stein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Phase I and pharmacokinetic trial of weekly CPT-11M L Rothenberg, J G Kuhn, H A Burris, et al.
Pageof 12